AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2018
Aug 21, 2018
33956_dirs_2018-08-21_e3f98f6e-715d-4893-a2a9-8274730b5ae7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-08-17
Reporting Person: Laube Lynne Marie (Director, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-17 | Common Stock | S | 1349 | $20.66 | Disposed | 420115 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 43675 | Indirect |
| Common Stock | 43675 | Indirect |
Footnotes
F1: Represents shares sold to cover taxes due upon the settlement of certain restricted stock unit grants.
F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT"). The Reporting Person is the trustee of the HMA GRAT.
F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT"). The Reporting Person is the trustee of the KGA GRAT.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26